title: Atypical antipsychotic prescribing and diabetes.
authors.forename: Mark
authors.initials: M
authors.lastname: Agius
authors.forename: Catherine Louise
authors.initials: CL
authors.lastname: Murphy
authors.forename: Alpha
authors.initials: A
authors.lastname: Win
authors.forename: Rashid
authors.initials: R
authors.lastname: Zaman
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001786:Blood Glucose / Q000378:metabolism; D003024:Clozapine / Q000008:administration & dosage / Q000009:adverse effects; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000139:chemically induced*; D006801:Humans; D018967:Risperidone / Q000008:administration & dosage / Q000009:adverse effects; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D001786:Blood Glucose; D003024:Clozapine; D018967:Risperidone